Andrew D. Dickinson, Chief Financial Officer of Gilead Sciences ($GILD), sold company shares on the open market 12 times over the past year, totaling $3.7 million. His most recent sale occurred on February 17, 2026. These transactions rank 2,345th among 11,678 insiders in our database, where the average sale amount is $8.6 million across 6.37 transactions. Dickinson made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 3000 | $144.23 | 179,191.0000 | 1,256,000,000 | 1.65% | 0.00% |
| March 10, 2026 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | A | Non-qualified Stock Option (Right to Buy) | 35880 | $0.00 | 35,880.0000 | 1,256,000,000 | 9999.99% | 0.00% |
| March 10, 2026 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | A | Restricted Stock Unit | 9590 | $0.00 | 30,647.0000 | 1,256,000,000 | 45.54% | 0.00% |
| March 10, 2026 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 6469 | $0.00 | 185,338.0000 | 1,256,000,000 | 3.62% | 0.00% |
| March 10, 2026 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 3147 | $148.56 | 182,191.0000 | 1,256,000,000 | 1.70% | 0.00% |
| March 10, 2026 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 6469 | $0.00 | 21,057.0000 | 1,256,000,000 | 23.50% | 0.00% |
| Feb. 27, 2026 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | A | Common Stock | 11090 | $0.00 | 178,869.0000 | 1,256,000,000 | 6.61% | 0.00% |
| Feb. 17, 2026 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 3000 | $154.43 | 167,779.0000 | 1,256,000,000 | 1.76% | 0.00% |
| Feb. 3, 2026 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 24802 | $143.28 | 170,568.0000 | 1,256,000,000 | 12.69% | 0.00% |
| Feb. 3, 2026 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | A | Common Stock | 44867 | $0.00 | 195,370.0000 | 1,256,000,000 | 29.81% | 0.00% |
| Jan. 15, 2026 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 3000 | $124.31 | 150,503.0000 | 1,256,000,000 | 1.95% | 0.00% |
| Dec. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 3000 | $122.00 | 153,503.0000 | 1,256,000,000 | 1.92% | 0.00% |
| Dec. 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 3693 | $0.00 | 27,526.0000 | 1,256,000,000 | 11.83% | 0.00% |
| Dec. 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 3693 | $0.00 | 158,248.0000 | 1,256,000,000 | 2.39% | 0.00% |
| Dec. 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 1745 | $121.34 | 156,503.0000 | 1,256,000,000 | 1.10% | 0.00% |
| Nov. 17, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $125.23 | 154,555.0000 | 1,256,000,000 | 1.59% | 0.00% |
| Oct. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $118.08 | 157,055.0000 | 1,256,000,000 | 1.57% | 0.00% |
| Sept. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $113.57 | 159,555.0000 | 1,255,000,000 | 1.54% | 0.00% |
| Sept. 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 3696 | $0.00 | 163,806.0000 | 1,255,000,000 | 2.31% | 0.00% |
| Sept. 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 1751 | $115.25 | 162,055.0000 | 1,255,000,000 | 1.07% | 0.00% |
| Sept. 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 3696 | $0.00 | 31,219.0000 | 1,255,000,000 | 10.59% | 0.00% |
| Aug. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $118.53 | 160,110.0000 | 1,255,000,000 | 1.54% | 0.00% |
| July 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $111.03 | 162,610.0000 | 1,255,000,000 | 1.51% | 0.00% |
| June 16, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $110.17 | 165,110.0000 | 1,255,000,000 | 1.49% | 0.00% |
| June 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 3694 | $0.00 | 169,368.0000 | 1,255,000,000 | 2.23% | 0.00% |
| June 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 3694 | $0.00 | 34,915.0000 | 1,255,000,000 | 9.57% | 0.00% |
| June 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 1758 | $110.09 | 167,610.0000 | 1,255,000,000 | 1.04% | 0.00% |
| May 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $99.82 | 165,674.0000 | 1,255,000,000 | 1.49% | 0.00% |
| April 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $106.40 | 168,174.0000 | 1,255,000,000 | 1.46% | 0.00% |
| March 17, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $110.53 | 170,674.0000 | 1,255,000,000 | 1.44% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 7968 | $0.00 | 177,029.0000 | 1,255,000,000 | 4.71% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | A | Restricted Stock Unit | 11090 | $0.00 | 38,609.0000 | 1,255,000,000 | 40.30% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 3855 | $117.21 | 173,174.0000 | 1,255,000,000 | 2.18% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 4916 | $0.00 | 13,013.0000 | 1,255,000,000 | 27.42% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 13013 | $0.00 | 0.0000 | 1,255,000,000 | 100.00% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 7968 | $0.00 | 27,519.0000 | 1,255,000,000 | 22.45% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | A | Non-qualified Stock Option (Right to Buy) | 49020 | $0.00 | 49,020.0000 | 1,255,000,000 | 9999.99% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 13013 | $118.50 | 169,061.0000 | 1,255,000,000 | 7.15% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 4916 | $117.30 | 182,074.0000 | 1,255,000,000 | 2.63% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 13013 | $63.91 | 186,990.0000 | 1,255,000,000 | 7.48% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 4916 | $63.91 | 173,977.0000 | 1,255,000,000 | 2.91% | 0.00% |
| Feb. 18, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $104.09 | 169,061.0000 | 1,255,000,000 | 1.46% | 0.00% |
| Feb. 12, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 15600 | $80.72 | 290,689.0000 | 1,255,000,000 | 5.67% | 0.00% |
| Feb. 12, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 18210 | $83.49 | 308,899.0000 | 1,255,000,000 | 6.26% | 0.00% |
| Feb. 12, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 137676 | $102.22 | 171,223.0000 | 1,255,000,000 | 44.57% | 0.01% |
| Feb. 12, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 77691 | $0.00 | 17,929.0000 | 1,255,000,000 | 81.25% | 0.01% |
| Feb. 12, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 26175 | $0.00 | 78,515.0000 | 1,255,000,000 | 25.00% | 0.00% |
| Feb. 12, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 15600 | $0.00 | 0.0000 | 1,255,000,000 | 100.00% | 0.00% |
| Feb. 12, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 18210 | $0.00 | 0.0000 | 1,255,000,000 | 100.00% | 0.00% |
| Feb. 12, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 26175 | $57.92 | 275,089.0000 | 1,255,000,000 | 10.52% | 0.00% |
| Feb. 12, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 77691 | $63.91 | 248,914.0000 | 1,255,000,000 | 45.37% | 0.01% |
| Feb. 4, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 43138 | $97.99 | 171,223.0000 | 1,255,000,000 | 20.12% | 0.00% |
| Feb. 4, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | A | Common Stock | 19793 | $0.00 | 149,666.0000 | 1,255,000,000 | 15.24% | 0.00% |
| Feb. 4, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | A | Common Stock | 64695 | $0.00 | 214,361.0000 | 1,255,000,000 | 43.23% | 0.01% |
| Jan. 31, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 26170 | $0.00 | 104,690.0000 | 1,255,000,000 | 20.00% | 0.00% |
| Jan. 31, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 71850 | $0.00 | 0.0000 | 1,255,000,000 | 100.00% | 0.01% |
| Jan. 31, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 142180 | $97.22 | 129,873.0000 | 1,255,000,000 | 52.26% | 0.01% |
| Jan. 31, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 44160 | $65.38 | 273,053.0000 | 1,255,000,000 | 19.29% | 0.00% |
| Jan. 31, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 71850 | $72.34 | 227,893.0000 | 1,255,000,000 | 46.05% | 0.01% |
| Jan. 31, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 26170 | $57.92 | 156,043.0000 | 1,255,000,000 | 20.15% | 0.00% |
| Jan. 31, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 44160 | $0.00 | 0.0000 | 1,255,000,000 | 100.00% | 0.00% |
| Jan. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $91.35 | 129,873.0000 | 1,255,000,000 | 1.89% | 0.00% |
| Dec. 16, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 8500 | $91.96 | 132,373.0000 | 1,254,000,000 | 6.03% | 0.00% |
| Dec. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 3640 | $0.00 | 142,559.0000 | 1,254,000,000 | 2.62% | 0.00% |
| Dec. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 3640 | $0.00 | 35,487.0000 | 1,254,000,000 | 9.30% | 0.00% |
| Dec. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 1686 | $92.34 | 140,873.0000 | 1,254,000,000 | 1.18% | 0.00% |
| Nov. 29, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 26170 | $57.92 | 183,719.0000 | 1,254,000,000 | 16.61% | 0.00% |
| Nov. 29, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 18630 | $73.77 | 157,549.0000 | 1,254,000,000 | 13.41% | 0.00% |
| Nov. 29, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 33660 | $68.75 | 217,379.0000 | 1,254,000,000 | 18.32% | 0.00% |
| Nov. 29, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 60885 | $71.91 | 278,264.0000 | 1,254,000,000 | 28.01% | 0.00% |
| Nov. 29, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 43340 | $72.70 | 321,604.0000 | 1,254,000,000 | 15.58% | 0.00% |
| Nov. 29, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 65960 | $72.70 | 387,564.0000 | 1,254,000,000 | 20.51% | 0.01% |
| Nov. 29, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 120715 | $92.77 | 266,849.0000 | 1,254,000,000 | 31.15% | 0.01% |
| Nov. 29, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 127930 | $92.76 | 138,919.0000 | 1,254,000,000 | 47.94% | 0.01% |
| Nov. 29, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 26170 | $0.00 | 130,860.0000 | 1,254,000,000 | 16.67% | 0.00% |
| Nov. 29, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 18630 | $0.00 | 0.0000 | 1,254,000,000 | 100.00% | 0.00% |
| Nov. 29, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 33660 | $0.00 | 0.0000 | 1,254,000,000 | 100.00% | 0.00% |
| Nov. 29, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 60885 | $0.00 | 0.0000 | 1,254,000,000 | 100.00% | 0.00% |
| Nov. 29, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 43340 | $0.00 | 0.0000 | 1,254,000,000 | 100.00% | 0.00% |
| Nov. 29, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 65960 | $0.00 | 0.0000 | 1,254,000,000 | 100.00% | 0.01% |
| Sept. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 3641 | $0.00 | 140,601.0000 | 1,258,000,000 | 2.66% | 0.00% |
| Sept. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 1682 | $81.44 | 138,919.0000 | 1,258,000,000 | 1.20% | 0.00% |
| Sept. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 3641 | $0.00 | 39,127.0000 | 1,258,000,000 | 8.51% | 0.00% |
| June 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 3639 | $0.00 | 42,768.0000 | 1,258,000,000 | 7.84% | 0.00% |
| June 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 1662 | $65.25 | 136,960.0000 | 1,258,000,000 | 1.20% | 0.00% |
| June 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 3639 | $0.00 | 138,622.0000 | 1,258,000,000 | 2.70% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 6707 | $0.00 | 28,333.0000 | 1,258,000,000 | 19.14% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | A | Restricted Stock Unit | 17305 | $0.00 | 46,407.0000 | 1,258,000,000 | 59.46% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 6707 | $0.00 | 139,488.0000 | 1,258,000,000 | 5.05% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 4505 | $75.12 | 134,983.0000 | 1,258,000,000 | 3.23% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 3025 | $0.00 | 35,040.0000 | 1,258,000,000 | 7.95% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | A | Non-qualified Stock Option (Right to Buy) | 87970 | $0.00 | 87,970.0000 | 1,258,000,000 | 9999.99% | 0.01% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 3025 | $0.00 | 132,781.0000 | 1,258,000,000 | 2.33% | 0.00% |
| Jan. 31, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | A | Common Stock | 55955 | $0.00 | 152,846.0000 | 1,258,000,000 | 57.75% | 0.00% |
| Jan. 31, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 23410 | $78.26 | 129,436.0000 | 1,258,000,000 | 15.32% | 0.00% |
| Jan. 31, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | A | Common Stock | 19006 | $0.00 | 96,891.0000 | 1,258,000,000 | 24.40% | 0.00% |
| Jan. 16, 2024 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 5000 | $85.78 | 101,534.0000 | 1,258,000,000 | 4.69% | 0.00% |
| Dec. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 2617 | $0.00 | 38,834.0000 | 1,262,000,000 | 6.31% | 0.00% |
| Dec. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 2617 | $0.00 | 107,728.0000 | 1,262,000,000 | 2.49% | 0.00% |
| Dec. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 1194 | $79.02 | 106,534.0000 | 1,262,000,000 | 1.11% | 0.00% |
| Nov. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 804 | $75.92 | 105,111.0000 | 1,262,000,000 | 0.76% | 0.00% |
| Nov. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 1912 | $0.00 | 41,451.0000 | 1,262,000,000 | 4.41% | 0.00% |
| Nov. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 1912 | $0.00 | 105,915.0000 | 1,262,000,000 | 1.84% | 0.00% |
| Oct. 17, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 5000 | $80.00 | 104,003.0000 | 1,262,000,000 | 4.59% | 0.00% |
| Sept. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 2619 | $0.00 | 43,363.0000 | 1,262,000,000 | 5.70% | 0.00% |
| Sept. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 2619 | $0.00 | 110,206.0000 | 1,262,000,000 | 2.43% | 0.00% |
| Sept. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 1203 | $76.00 | 109,003.0000 | 1,262,000,000 | 1.09% | 0.00% |
| July 20, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 5000 | $80.00 | 107,587.0000 | 1,262,000,000 | 4.44% | 0.00% |
| June 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 1219 | $78.12 | 73,701.0000 | 1,262,000,000 | 1.63% | 0.00% |
| June 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 2618 | $0.00 | 45,982.0000 | 1,262,000,000 | 5.39% | 0.00% |
| June 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 2618 | $0.00 | 74,920.0000 | 1,262,000,000 | 3.62% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 7394 | $0.00 | 116,037.0000 | 1,262,000,000 | 6.81% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 7394 | $0.00 | 32,250.0000 | 1,262,000,000 | 18.65% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | A | Restricted Stock Unit | 16350 | $0.00 | 48,600.0000 | 1,262,000,000 | 50.70% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | A | Non-qualified Stock Option (Right to Buy) | 74565 | $0.00 | 74,565.0000 | 1,262,000,000 | 9999.99% | 0.01% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 4849 | $79.50 | 111,188.0000 | 1,262,000,000 | 4.18% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 3025 | $0.00 | 39,644.0000 | 1,262,000,000 | 7.09% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 3025 | $0.00 | 108,643.0000 | 1,262,000,000 | 2.86% | 0.00% |
| Feb. 15, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | A | Common Stock | 376 | $56.38 | 105,618.0000 | 1,262,000,000 | 0.36% | 0.00% |
| Feb. 6, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 1817 | $0.00 | 42,669.0000 | 1,262,000,000 | 4.08% | 0.00% |
| Feb. 6, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 531 | $86.36 | 105,242.0000 | 1,262,000,000 | 0.50% | 0.00% |
| Feb. 6, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 1817 | $0.00 | 105,773.0000 | 1,262,000,000 | 1.75% | 0.00% |
| Jan. 24, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | A | Common Stock | 38270 | $0.00 | 119,283.0000 | 1,262,000,000 | 47.24% | 0.00% |
| Jan. 24, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | A | Common Stock | 27932 | $0.00 | 81,013.0000 | 1,262,000,000 | 52.62% | 0.00% |
| Jan. 24, 2023 | GILEAD SCIENCES, INC. | $GILD | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 15327 | $84.02 | 103,956.0000 | 1,262,000,000 | 12.85% | 0.00% |